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TUG and SCT times (sec) at each time point. Values expressed as
mean (95% CI)
Baseline 1 year 2 year
TUG 8.29 (7.95, 8.62) 7.82 (7.53, 8.12) 7.92 (7.56, 8.29)
SCT 13.71 (12.86, 14.56) 12.49 (11.70, 13.28) 12.67 (11.87, 13.46)
Recovery Status on TUG and SCT for patients at 2 year follow-up (Values
expressed as percentages).
Recovered Improved to
Recovered
Improved Unchanged Deteriorated
TUG 33.1 6.6 14.0 38.0 8.3
SCT 29.8 5.0 13.2 47.9 4.1
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CHANGE IN CARTILAGE THICKNESS IN THE FEMOROPATELLATAR
JOINT AFTER ACUTE ANTERIOR CRUCIATE LIGAMENT TEAR – LONG
TERM FOLLOW-UP
S. Cotofana y,z, W. Wirth y,z, F. Eckstein y,z, M. Hudelmaier y,z,
S. Lohmander x, R.B. Frobell x. y PMU-Salzburg, Salzburg, Austria;
zChondrometrics GmbH, Ainring, Germany; xOrthopedics, Clinical Sci.
Lund, Lund University, SwedenTable 1
Change in cartilage thickness between BL-2 years and 2-5 years. Asterisks indicate differences from zero (** p<0.001) within strata for age, BMI and gender (left side); p-values
highlighted in bold indicate signiﬁcances between these strata (right side).
Age<median
(n¼54) Mean /mm
Age<median
(n¼54) SEM
Age>median
(n¼53) Mean /mm
Age>median
(n¼53) SEM
Mean
Difference /mm
Lower 95% CI Upper 95% CI p (2-tailed)
Patella 2.33 10.88 -20.41 13.84 80.29 11.81 148.78 0.022
ACL tear -> 2 years Trochlea -16.38 14.68 -73.94** 15.95 57.56 14.59 100.52 0.009
Patella 14.98 11.34 -22.86 14.36 138.32 43.96 232.68 0.004
2 -> 5 years Trochlea 8.97 9.25 -11.22 11.32 20.19 -8.75 49.13 0.17
BMI<median
(n¼53) Mean /mm
BMI<median
(n¼53) SEM
BMI>median
(n¼54) Mean /mm
BMI>median
(n¼54) SEM
Mean
Difference /mm
Lower 95% CI Upper 95% CI p (2-tailed)
Patella -12.66 13.51 -5.29 11.47 -7.37 -42.45 27.72 0.678
ACL tear -> 2 years Trochlea -22.38 16.18 -66.99** 14.86 44.61 1.08 88.15 0.045
Patella -1.48 13.62 -6.01 12.72 4.54 -32.40 41.47 0.808
2 -> 5 years Trochlea 6.65 10.19 -8.57 10.52 15.22 -13.84 44.27 0.301
Male (n¼81)
Mean /mm
Male (n¼81)
SEM
Female (n¼26)
Mean /mm
Female (n¼26)
SEM
Mean
Difference /mm
Lower
95% CI
Upper
95% CI
p (2-tailed)
Patella -14.46 10.38 8.26 16.29 -22.71 -63.41 17.99 0.271
ACL tear -> 2 years Trochlea -48.50** 13.35 -33.63 19.55 -14.87 -66.53 36.79 0.569
Patella -2.99 10.48 -6.20 20.14 3.21 -39.86 46.28 0.883
2 -> 5 years Trochlea -0.78 8.43 -1.82 15.11 1.04 -33.00 35.08 0.952Purpose: Patellofemoral joint (PFJ) osteoarthritis (OA) is a prevalent
disease affecting young and elderly individuals and is recognized as
a potent source of knee symptoms. Using quantitative MR image anal-
ysis it was reported that the femoral trochlea undergoes cartilage
thinning within the ﬁrst two years after an ACL tear and that such
thinning wasmore frequent in older individuals. It is however unknown
whether these changes continue (and if yes, at which magnitude) over
longer follow-up periods. Thus, the purpose of the present work was to
study the rate of change in cartilage thickness in the PFJ during the
period of 2-5years after ACL tear and to explore differences related to
age, gender and BMI.
Methods: 121 young active adults (32 women, 26.04.9 years) with an
acute ACL tear were included in a randomized control trial (the
KANON-trial). The study compared rehabilitation plus early ACL
reconstruction (n¼62), with rehabilitation plus the option of having
delayed ACL reconstruction if needed (n¼59). Mean cartilage thickness
was assessed by manual segmentation in the patella and femoral
trochlea with blinding to time points and treatment groups. Crude and
adjusted (age, sex & BMI) statistical testing was performed to explore
the magnitude of cartilage loss between baseline (BL, within 4 weeksfrom ACL tear)-2years and 2-5years in the patella and the femoral
trochlea.
Results: 107 of 121 participants had a complete set of MR images at BL,
2 and 5 year follow up. Mean change of cartilage thickness in patella and
trochlea was -8.9mm/[-26.4, 8.5] and -44.9mm/[-67.0, -22.8] (mean/[95%
CI]) over the ﬁrst 2 years after ACL tear and -3.8mm/[-22.1, 14.6] and
-1.0mm/[-15.6, 13.5] over the period between 2-5 years, respectively.
Older patients (above median age, 25.63years) lost signiﬁcantly more
cartilage thickness than younger individuals (below median age) in
both the patella (p¼0.022) and in the trochlea (p¼0.009) over the ﬁrst 2
years. Similar differences were seen in the patella (p¼0.004), but not in
the trochlea (p¼0.17), between 2-5years (Table 1). Compared to indi-
viduals with a lower BMI (belowmedian, 23.66kg/m2), individuals with
a higher BMI (above median) had a signiﬁcant decrease in cartilage
thickness of the trochlea over the ﬁrst 2 years (p¼0.045) but not
between 2-5years. No corresponding differences related to BMI or
gender were observed in the patella (Table 1). In a multi-variate model
including age, BMI and gender, older age at ACL tear signiﬁcantly
increased the odds of losing cartilage thickness in the femoral trochlea
(OR 1.06, 95% CI 1.01, 1.10) over the ﬁrst 2 years after tear and in the
patella (OR 1.04, 1.00, 1.08) in the period 2-5 years.
Conclusions: These results show that cartilage loss in the femoral
trochlea may be an early and temporary event occurring over the ﬁrst 2
years after ACL tear. In contrast to that, cartilage loss in the patellar
cartilage seems to occur later than 2 years after the ACL tear. Older age
seems to be a risk factor for these changes. Our results indicate that
different mechanisms may drive loss of cartilage in the femoropatellar
joint after ACL tear.276
THE VISK STUDY: A PRAGMATIC RANDOMIZED CLINICAL TRIAL FOR
THE EFFECTIVENESS OF INTRA ARTICULAR HYALURONIC ACID FOR
KNEE OSTEOARTHRITIS
J. Hermans y, S.M. Bierma-Zeinstra y, D. Niesten z, J.A. Verhaar y,
M. Reijman y. y Erasmus MC, Rotterdam, The Netherlands; zReinier de
Graaf Hosp., Delft, The Netherlands
Purpose: Usual care for knee osteoarthritis (OA) consists of non-
steroidal anti-inﬂammatory drugs (NSAIDs) combined with physical
therapy. Nevertheless, NSAIDs may cause serious gastrointestinal
symptoms. An alternative treatment for knee OA is intra articular
injections with hyaluronic acid (HA), showing beneﬁcial results on pain,
function and patient global assessment. However, limited evidence of
the additional value of HA to usual care exists. Therefore, the goal of this
investigation was to assess the clinical relevant effect of intra articular
high molecular weight (MW) HA added to usual care compared to usual
care in patients with knee OA.
Methods: Clinical effectiveness and cost utility were investigated
simultaneously in this randomized clinical trial. Consecutive knee OA
